Companies: 10,795·Total market cap: $144.5T
Veradigm Inc.

Veradigm Inc.

MDRXOTCHealthcare● Active
$4.58
$-0.42(-8.45%)
Market Cap$777396825
P/E Ratio—
52W High$6
52W Low$3
SEC Filings

Veradigm Inc. (MDRX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001124804 · MDRX · OTC · as of Jun 9, 2026

Filing snapshot

1,005+
Total Filings
4
Latest Form
2026-06-03
Most Recent
1999
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001124804 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-05-26
Fiscal Year End
May 26, 2026
Accession No.
0001193125-26-239413
Primary Document
mdrx-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001124804 · Accession 0001193125-26-239413

Latest Key Filings

10-QQuarterly Report
10-Q
2022-11-07
View 10-Q on SEC
8-KCurrent Report
8-K/A
2026-05-26Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
3Initial Statement of Beneficial Ownership
3
2026-05-27
View
8-K/ACurrent Report (Amended)
8-K/A
2026-05-26
View
10-KAnnual Report
10-K
2026-05-26
View
8-KCurrent Report
8-K
2026-05-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
NT 10-QNT 10-Q
NT 10-Q
2026-05-12
View
8-KCurrent Report
8-K
2026-04-06
View
NT 10-KNT 10-K
NT 10-K
2026-03-17
View
8-KCurrent Report
8-K
2026-02-24
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
8-KCurrent Report
8-K
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
Showing 1–15 of 503 filingsForm 4 / 144 hidden· 1005 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001124804  |  Exchange: OTC · Healthcare

Veradigm Inc. (OTC: MDRX) has submitted 1,005+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1999. As a Healthcare sector company with CIK 0001124804, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Veradigm Inc.'s most comprehensive regulatory disclosure. The most recent Veradigm Inc. 10-K was filed on 2026-05-26 for fiscal year ending 2026. Historical MDRX 10-K annual reports are available from 2012 through 2026.

Investors researching Veradigm Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
TSUSF SEC Filings →SMSZF SEC Filings →SAFLF SEC Filings →WHTCF SEC Filings →ARRJF SEC Filings →LFTSF SEC Filings →ELEAF SEC Filings →TGRNF SEC Filings →
→ MDRX Financials→ MDRX Earnings→ MDRX Insider Trades

Frequently Asked Questions

MDRX SEC Filings · 8 questions

Veradigm Inc. (MDRX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,005+ filings and access original documents at no cost. Veradigm Inc.'s CIK is 0001124804.

MDRX SEC filingsVeradigm Inc. SEC documentsfind MDRX 10-K